Macrophages play a critical role in chronic inflammation and metabolic diseases. We identified a longer splice variant of ubiquitin specific protease (USP) 2-69 as a novel molecule that modulates pathways implicated in metabolic disorders. Expression levels of aP2/ FABP4 and PAI-1/SERPINE1 genes were increased by 4-and 1.8-fold, respectively, after short hairpin RNA-mediated knockdown (KD) of the USP2 gene, and such expression was alleviated by overexpression of USP2-69 in human myeloid cell lines. Supernatants derived from USP2-KD cells induced IL6 (ϳ6-fold) and SAA3 (ϳ15-fold) in 3T3-L1 adipocytes to suggest the anti-inflammatory properties of USP2. In addition, we observed a 30% decrease in the number of macrophages in mesenteric adipose tissue derived from USP2-69 transgenic mice fed a high-fat diet for 14 wk compared with that in their C57BL/6 littermates (P<0.01), which was consistent with a ϳ40% decrease in transcription of aP2 and PAI-1. The aP2 locus exhibited elevated chromatin accessibility (>2.1-fold), methylation of histone H3 lysine 4 (>4.5-fold), and acetylation of histone H4 (>2.5-fold) in USP2-KD cells. Transfection of isopeptidase-mutated USP2-69 did not alter chromatin conformation on the aP2 locus in USP2-KD cells. Our results suggest that USP2-69 suppresses meta-inflammatory molecules involved in the development of type-2 diabetes.-Kitamura, H., Kimura, S., Shimamoto, Y., Okabe, J., Ito, M., Miyamoto, T., Naoe, Y., Kikuguchi, C., Meek, B., Toda, C., Okamoto, S., Kanehira, K., Hase, K., Watarai, H., Ishizuka, M., El-Osta, A., Ohara, O., Miyoshi, I. Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammation. FASEB J. 27, 4940 -4953 (2013). www.fasebj.org
these same molecules causes chronic inflammation ("metainflammation") in adipose tissues, culminating in type 2 diabetes. Although several studies have clarified the molecular events leading to the release of the deterioration molecules from ATMs (3, 5, 6) , the mechanisms remain poorly understood.
Ubiquitination and deubiquitination are reversible processes that control the molecular characteristics of target proteins. Deubiquitination is carried out by a group of ϳ85 ubiquitin-specific proteases (USPs; ref. 7) . Within this group, USP2 contributes to various cellular events including carcinogenesis, spermatogenesis, and ion channel regulation (8) (9) (10) . In addition, the finding that insulin and adiponectin alter USP2 expression in brain and cancer cells suggests that USP2 also plays a role in regulating glucose metabolism (11, 12) . USP2 has 2 major variants in humans and mice, namely USP2-45 and USP2-69 (Fig. 1A and refs. 13, 14) . Both variants have a common ubiquitin isopeptidase domain at the C terminus, whereas the structure of the N terminus varies in sequence. Recently, Molusky et al. (15) demonstrated that USP2-45, but not USP2-69, promotes gluconeogenesis in hepatocytes, indicating distinct roles of the USP2 variants in glucose metabolism. In this study, we evaluate the expression and function of these two USP2 variants in macrophages using a myeloid cell line and mice. We also elucidate the molecular mechanisms that underlie the USP2-mediated events in macrophages.
MATERIALS AND METHODS

Cell lines and reagents
The human myeloid cell lines HL-60, THP-1 (RIKEN, Tsukuba, Japan), and U937 [American Type Culture Collection (ATCC), Manassas, VA, USA] were treated with 30 nM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, St. Louis, MO, USA) for 1Ϫ3 d. 3T3-L1 cells (ATCC) were differentiated using an adipogenic medium (Takara, Otsu, Japan) for 7 d. HeLa cells were obtained from ATCC. Gö6850 and Gö6983 were obtained from Millipore (Billerica, MA, USA). To assess the effects of USP2-knockdown (KD) cells on 3T3-L1 cells, USP2-KD cells and control cells were cultured in Opti-MEM medium (Life Technologies, Carlsbad, CA, USA) supplemented with PMA (30 nM) for 5 d. The supernatants from the culture medium were diluted 2-fold and added to differentiated 3T3-L1 cells for 3 and 6 h.
Generation of USP2-KD, USP2, and isopeptidase-mutated
USP2-restored cells
To generate USP2-KD cells, we used a BLOCK-iT kit (Life Technologies) to construct a lentivirus vector to deliver the green fluorescent protein (GFP) gene and short hairpin RNA (shRNA) against USP2 mRNA. The targeting sequence of this construct was 5=-CCTCGTGGAAGAGTTTGCAAA-3=. After packaging, recombinant viruses encoding USP2-targeting shRNAs or control shRNAs were used to infect HL-60 cells. Subsequently, cells expressing GFP were sorted by a FACSAria II cell sorter (BD Biosciences, San Jose, CA, USA).
To restore USP2 expression, we infected USP2-KD cells with lentivirus vector encoding USP2-69 or USP2-45 with a synonymous mutation in the shRNA targeting site, 5=-CCTCGTGGAA-GAGTTCGCCAA-3=. The mutated USP2-69 and USP2-45 fragments were introduced into the CSII-CMV-RfA-IRES2-mutRFP vector (provided by Dr. Hiroyuki Miyoshi, RIKEN). A point mutation was introduced at the nucleophile site (cysteine 276Ϫalanine 276) of the isopeptidase region of the USP2-69 expression vector using an oligonucleotide to create a isopeptidase-inactive mutant of USP2-69 (16) . The sequences of the oligonucleotide were 5=-TGAGTTCATGAAGGCCGTGTTCCCAAGG-3= and 5=-ATTCTGCAGTGCCTGAGCAACACTCGG-3=. After lentivirus infection, the double GFP ϩ /RFP ϩ -labeled cells were sorted by a FACSAria II cell sorter.
mRNA analyses
Total RNA was subjected to microarray analysis using Human U133 2.0 GeneChips (Affymetrix, Santa Clara, CA, USA) and SurePrint G3 Mouse GE microarrays (Agilent, Santa Clara, CA, USA). Microarray data were analyzed using the GeneSpring GX program (Agilent). A change in the gene expression level was deemed "significantly affected" when there was more than a 2-fold change in expression level, and the gene was significantly (PϽ0.05) affected at Ͼ2 consecutive time points (Supplemental Fig. S2A ). Genes were also significantly affected if a Ͼ2-fold change was observed in multiple stepwise comparisons (see Fig. 5 and Table 1 ). The DAVID program (http://david.abcc.ncifcrf. gov/) was used to assess the microarray data and identify the enrichment of genes within distinct biological themes. All microarray data were deposited in Gene Expression Omnibus (accession nos. GSE20476 and GSE43313).
Northern blot analysis using cDNA probes (ϩ250 to ϩ825 bp of NM_004205.3 andϩ26 to ϩ325 bp of NM_171997.1) was performed as described previously (17) . Membranes were stained with methylene blue as a reference. cDNA was prepared with Molony murine leukemia virus reverse transcriptase (Life Technologies) and WT-Ovation kits (NuGEN, San Carlos, CA, USA). Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis was performed using LightCycler480 (Roche, Basel, Switzerland) and Eco (Illumina, San Diego, CA, USA) systems. TaqMan mixtures for human 18S rRNA and USP2-45 and USP2-69 were purchased from Life Technologies. Sequences of mouse USP2 variants were 5=-TATGGCACCTA-(Abbreviations continued) tissue macrophage; CCL, C-C chemokine ligand; C/EBP, CCAAT-enhancer-binding protein; ChIP, chromatin immunoprecipitation; CXCL, CXC chemokine ligand; Cy, cyanine; EGFP, enhanced green fluorescent protein; ERK, extracellular signal-regulated kinase; FIRE, fms intronic regulatory element; GAPDH, glyceraldehyde-3-phospate dehydrogenase; GFP, green fluorescence protein; H3K4me1, histone H3 lysine 4 monomethylation; H3K4me2, histone H3 lysine 4 dimethylation; H3K4me3, histone H3 lysine 4 trimethylation; H3K9me1, histone H3 lysine 9 monomethylation; H3K9me2, histone H3 lysine 9 dimethylation; H3K9me3, histone H3 lysine 9 trimethylation; H4K5ac, histone H4 lysine 5 acetylation; H4K8ac, histone H4 lysine 8 acetylation; H4K12ac, histone H4 lysine 12 acetylation; H4K16ac, histone H4 lysine 16 acetylation; HA, hemagglutinin; HBB, hemoglobin ␤; HFD, high-fat diet; HMGA2, high-mobility group AT-hock 2; HPRT-1, hypoxanthine phosphoribosyltransferase 1; IL-6, interleukin-6; JNK, c-Jun NH 2 -terminal kinase; KD, knockdown; LMB, leptomycin B; MAPK, mitogen-activated protein kinase; MMP, matrix metalloproteinase; NF-B, nuclear factor-B; PAI-1, plasminogen activator inhibitor-1; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; PN-1, protein nexin-1; qRT-PCR, quantitative reverse transcriptase-polymerase chain reaction; SAA3, serum amyloid A3; RPS3, ribosomal protein small subunit 3; shRNA, short-hairpin RNA; SOCS3, suppressor of cytokine signaling 3; TG, transgenic; USP, ubiquitin specific protease CACCCCTTC-3= and 5=-CCCCTGTCACAGTCCAGAAT-3= for USP2-69 and 5=-GCGTACCTCCTACACGGTGA-3= and 5=-TCT-TGGCTTTGTTGAGCAGA-3= for USP2-45. Sequences of the other primers can be downloaded from our web page (http:// www.med.nagoya-cu.ac.jp/animal.dir/animalweb/dcem/ dataset_dcem_en.html).
Western blot and suspension array analyses
Western blot analysis was performed as described previously (18) . Protein samples were stained with Coomassie Brilliant Blue (Nacalai, Kyoto, Japan). Anti-USP2 antibodies were purchased from Proteintech (Chicago, IL, USA) and Abgent (San Diego, CA, USA). Anti-phospho-protein kinase C (PKC) ␤II, ribosomal protein small subunit 3 (RPS3), adipocyte protein 2 (aP2), and high-mobility group AT-hock 2 (HMGA2) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). An anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Chemiluminescence signals were visualized using ChemiLumi One Super reagent (Nacalai) and scanned using a LAS1000 analyzer (Fujifilm, Tokyo, Japan).
Suspension array analysis was performed using a Bio-Plex system (Bio-Rad, Hercules, CA, USA) with antibody beads 
Mice and macrophages
Male ob/ob mice and their littermates were obtained from Japan SLC (Shizuoka, Japan). USP2-69 transgenic (TG) mice ϩ RNA (top 2 panels) and 1 g of total RNA (bottom 2 panels) were subjected to analysis. Methylene blue (MB) staining is shown as reference. C) Representative images of Western blots displaying USP2 variants and phospho-PKC ␤II (P-PKC). Ribosomal protein S3 (RPS3) was also detected as reference. D) Time course of change in mRNA levels of USP2 variants after PMA and vehicle application. Data were normalized according to the level of 18S rRNA (meansϮsd of 5 samples).
were generated by developmental engineering. The CAG promoter region of the pPyCAG-EGFP-IP vector (provided by Dr. Hitoshi Niwa, RIKEN) was substituted with the mouse fms intronic regulatory element (FIRE; ref. 19) , yielding the pPyFIRE-EGFP-IP vector. USP2-69 cDNA amplified from mouse splenic cDNA was cloned into the enhanced green fluorescence protein (EGFP) region of pPyFIRE-EGFP-IP (pPyFIRE-USP2-69-IP). A SalI-BsaBI digested fragment with both FIRE and USP2-69 cDNA was injected into C57BL/6 mice eggs (see Fig. 7A ).
Male USP2-69 TG mice and control littermates were fed a 60% kcal high-fat diet (HFD; Research Diets, New Brunswick, NJ, USA) from 5 to 19 wk of age. The vascular stromal fraction of epididymal and mesenteric adipose tissues was prepared as described previously (20) . Phosphate-buffered saline-suspended peritoneal cells were collected by a 10-ml syringe with an 18-gauge needle. Macrophages in the vascular stromal fraction of adipose tissue and peritoneal fluid were stained with both phycoerythrin-conjugated F4/80 and Alexa Fluor 488-conjugated CD11b antibodies (BioLegend, San Diego, CA, USA) and were sorted using a FACSAria II cell sorter.
All animal experiments were approved by the Animal Committee of Nagoya City University.
Immunohistochemistry and immunocytochemistry
Immunohistochemical staining of galectin-3 was performed as described previously (21) . Human USP2 cDNA fragments were inserted into pEGFP-N2 (Clontech, Mountain View, CA, USA) and pcDNA3-HAC (provided by Dr. Hiroyuki Takatsu, Kyoto University, Kyoto, Japan) to create the tagged protein expression constructs (USP2-EGFP and USP2-HA). The resultant constructs were transfected into HeLa cells using Lipofectamine LTX reagent (Life Technologies). The transfected cells were treated with leptomycin B (LMB, 5 ng/ml; SigmaAldrich) for 2 h. USP2-HA was detected using an antihemagglutinin (HA) antibody (Roche) and a cyanine (Cy) 3-conjugated anti-rat IgG antibody (Jackson ImmunoResearch, West Grove, PA, USA). HL-60 cells were treated with LMB (2.5 ng/ml) for 2 h, fixed with methanol, and reacted with antibodies against the C-terminal common region of both USP2 variants, the N-terminal region of USP2-69 (Abgent) or rabbit normal serum (Cedarlane, Burlington, ON, Canada). Cy3-conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch) was used as a secondary antibody. The cells were observed using a FV300 confocal microscope (Olympus, Tokyo, Japan). Nuclei were stained with TO-PRO-3 (Life Technologies).
Chromatin accessibility and chromatin immunoprecipitation (ChIP) analyses
Chromatin accessibility was evaluated with an EpiQ chromatin analysis kit (Bio-Rad) using the hemoglobin ␤ (HBB) gene as a reference. Sequences of the PCR primer for the chromatin accessibility test were 5=-TGCACTGAGCATTAAGCTGTCAAA-ACA-3= and 5=-GGGTGCTGTGACCCTCTTGAGTCCA-3= for aP2, 5=-CGCCGAGGCAGTTGTATTTCGGATG-3= and 5=-CCT-GCCCCAAGATTCAAGTGGGATG-3= for HMGA2, and 5=-AA-GCCAGTGCCAGAAGAGCCAAGGA-3= and 5=-CCCACAGGGC-AGTAACGGCAGACTT-3= for HBB. ChIP-PCR was performed using a commercial kit (Cell Signaling Technology). Antibodies against histone H3, histone H3 lysine 4 monomethylation (H3K4me1), dimethylation (H3K4me2), and trimethylation (H3K4me3), histone H3 lysine 9 monomethylation (H3K9me1), dimethylation (H3K9me2), and trimethylation (H3K9me3), and acetylated histone at lysine 5 (H4K5ac), 8 (H4K8ac), 12 (H4K12ac), and 16 (H4K16ac) were from Cell Signaling Technology, Abcam, and Millipore. Sequences of aP2 ChIP-PCR primers were 5=-CCGAAGAGCCTTTGCAATTA-3= and 5=-CCCAGTGTAGAGAGGGGAAA-3=.
Statistical analysis
Statistical analysis was performed by 1-way analysis of variance (ANOVA) followed by Tukey's post hoc test or Fisher's protected least significant difference test, 2-way repeated-measures ANOVA, or Student's t test.
RESULTS
PKC mediates changes in exon usage of the USP2 gene during macrophage-like differentiation of myeloid cell lines
Mature M1 macrophages accumulate in adipose tissues of obese individuals, resulting in metabolic abnormality. Elucidation of differentiation-elicited molecular events in macrophages advances understanding of the pathogenesis of type 2 diabetes. The human myeloid cell lines HL-60, THP-1, and U937 differentiate into macrophage-like cells in the presence of the canonical PKC activator, PMA (22) (23) (24) . We screened for molecules that can change exon usage during differentiation. USP2 (Fig. 1A ) was 1 of 16 molecules identified after PMA application; USP2-45 was up-regulated, whereas USP2-69 was down-regulated (Fig. 1B) . Consequently, 1 d after PMA application, USP2-45 accumulated considerably, whereas USP2-69 became undetectable (Fig. 1C) . The changes in expression of both variants were detected at 12 h after PMA application and sustained for Ն3 d (Fig. 1D) . The PMA-elicited expression changes in USP2 variants were mostly restored by the PKC inhibitors Gö6850 and Gö6983, indicating the involvement of PKC in this response (Fig. 1E ). These results suggest that the expression changes in USP2 are mediated by a PKC-dependent pathway.
Characterization of USP2-KD macrophage-like cells
To clarify the biological processes regulated by USP2 variants, we generated USP2-KD HL-60 cells using a lentivirus-driven shRNA expression system. As shown in Fig. 2A , USP2-45 and USP2-69 transcripts were reduced by ϳ80% in USP2-KD cells. Consistent with the gene expression, protein levels of each variant were also reduced in USP2-KD cells.
We compared the growth curves of USP2-KD and control cells (Supplemental Fig. S1A ). Although cells proliferated normally in regular growth medium, proliferation was attenuated in the presence of PMA. Furthermore, there was no significant difference in cell cycle progression (Supplemental Fig. S1B ) or surface expression of the pan-macrophage marker CD11b or M1 macrophage marker CD11c (Supplemental Fig. S1C ). The M2 macrophage marker CD163 was not detected (data not shown). Accumulation of apoptotic cells was comparable between USP2-KD and control cells (Supplemental Fig. S1D ). Overall, a deficiency in USP2 did not affect proliferation or differentiation of the myeloid cell line.
To explore how gene expression was modulated by the USP2 variants, we conducted transcriptome analysis of USP2-KD and control cells using Affymetrix GeneChips. Our analysis showed that the expression of 27 genes was significantly changed in USP2-KD cells, either 0, 1, 2, or 3 d after PMA application (Supplemental Fig.  S2A ). Expression changes in 19 of these genes were confirmed by qRT-PCR analysis (Supplemental Fig. S2 B), and these included several genes associated with metabolic abnormality. For example, expression of aP2/fatty acid-binding protein 4, known to exacerbate type 2 diabetes and atherosclerosis (25) , was strongly induced in USP2-KD cells (Fig. 2BϪD) . The plasminogen activator inhibitors PAI-1/serpine1 and protease nexin-1 (PN-1)/serpine2 were also up-regulated in USP2-KD cells (Fig. 2B, F) . In addition, USP2-KD cells also had enhanced expression of HMGA2 (Fig. 2B, C) , which is encoded at a susceptibility locus for type 2 diabetes and found in increased amounts in the fat pads of obese individuals (26, 27) .
Tissue remodeling is a feature of the metabolic syndrome and is characterized by secretion of metalloproteases from macrophages at lesions, such as obese adipose tissues and atherosclerosis plaques (4, 28) . As shown in Fig. 2B , F, mRNA and protein levels of MMP1 and MMP7 were markedly increased in USP2-KD cells.
Leukocyte infiltration into adipose tissues is another characteristic of metabolic syndrome, and chemokines, such as CCL2, are thought to contribute to this process (3) . In agreement with microarray data, qRT-PCR analysis confirmed increased expression of CCL1 and CCL2 in USP2-KD cells (Fig. 2E) . Moreover, qRT-PCR analysis of an additional 35 chemokines demonstrated that USP2-KD potentiated expression of CCL4, CCL7, CCL22, CCL24, CXCL5, CXCL7, and CXCL8 transcripts after PMA stimulation (Fig. 2E) . CCL2, CCL7, and CXCL7 proteins were also accumulated in the supernatant of USP2-KD cells (Fig. 2G) . These results suggest that USP2 attenuates the production of chemokines in macrophage-like cells.
USP2-69 is responsible for down-regulation of molecules implicated in metabolic disorders
To clarify which USP2 variant is primarily responsible for the down-regulation of molecules implicated in metabolic disorders, we overexpressed gene constructs encoding USP2-69 or USP2-45 in USP2-KD cells. As shown in Fig. 3A , introduction of these constructs restored (R) expression of each USP2 variant at both mRNA and protein levels. Figure 3B , C displays mRNA and protein levels of aP2, HMGA2, PAI-1, PN-1, and MMPs in USP2-69R and USP2-45R cells, respectively. These molecules were markedly reduced in USP2-69R cells compared with those in USP2-KD cells, whereas their expression was augmented in USP2-45R cells. Thus, USP2-69 is responsible for repression of the metabolic disorder-associated molecules on differentiation.
We also examined mRNA levels of chemokines in USP2-69R and USP2-45R cells. Similarly to the aforementioned genes, the mRNA levels of CCL1, CCL2, CCL4, CCL7, CCL24, and CXCL7 were strongly repressed in USP2-69R cells, compared with those in USP2-KD cells (Fig. 3D) . Transcripts encoding the CCL chemokines were also decreased in USP2-45R cells, whereas CXCL7 transcripts were increased. Hence, both USP2 variants predominantly repressed the induction of CCL chemokines in macrophage-like cells.
Isopeptidase region of USP2-69 is required for the regulation of genes implicated in metabolic disorders
We further investigated the roles of the C-terminal ubiquitin isopeptidase region of USP2-69 in the control of expression of the metabolic disorder-associated genes. We introduced an amino acid substitution at the nucleophile site (C276ϪA276) into a USP2-69 expression construct (Fig. 1A) to diminish the enzymatic activity and then transfected into USP2-KD cells (C276AR cells). As shown in Fig. 4A , mRNA and protein levels of USP2-69 were almost identical between USP2-69R cells and C276AR cells. We next monitored the mRNA and protein levels of aP2 and HMGA2 (Fig. 4B) . As shown before, USP2-69R cells clearly decreased both protein and mRNA levels of aP2 and HMGA2, whereas the C276AR cells displayed increased expression of these molecules. C276AR cells also failed to decrease transcripts for PAI-1, MMP-1, and MMP-7, CCL1, CCL2, CCL4, CCL24, and CXCL7, whereas C276AR cells exhibited partial or more drastic decreases in transcripts for PN-1 and CCL7, respectively (Fig. 4C) . Clearly, the isopeptidase region of USP2-69 is required for regulation of metabolic disorder-associated molecules.
Paracrine secretion from USP2-KD cells modulates gene expression of 3T3-L1 adipocytes
We also assessed the transcriptome of 3T3-L1 cells after conditioning with medium containing supernatant from USP2-KD cells and found that 62 genes were expressed at higher levels in 3T3-L1 cells. The GeneSpring GX pathway program indicated that expression levels of genes in adipogenic, inflammatory, and senescent pathways were significantly perturbed in 3T3-L1 cells treated with the USP2-KD cell-derived supernatant (Table 1) . Moreover, DAVID, which is a functional annotation program of microarray candidates based on Gene Ontology, indicated that addition of the supernatant to 3T3-L1 cells induced a cluster of secreted proteins (the enrichment score was 4.46, which is equivalent to Pϭ0.000035), which included inflammatory molecules such as interleukin-6 (IL-6) and serum amyloid A3 (SAA3; Fig. 5A ). Transcriptional activation of these proinflammatory and adipogenic molecules by the USP2-KD cell-derived supernatant was confirmed by qRT-PCR analysis (Fig. 5B) . Overall, USP2 in macrophages regulates adipocyte function through paracrine secretion of the soluble molecules.
Aberrant expression of USP2-69 in ATMs from ob/ob mice
Given that USP2-69 is a key modulator of metabolic disorders, we evaluated the expression levels of USP2-69 and USP2-45 in F4/80 ϩ and CD11b ϩ ATMs isolated from obese ob/ob mice and their lean littermates. For this purpose, we examined epididymal adipose tissue, in which macrophages are relatively abundant, even in lean mice. As expected, aP2, HMGA2, and PAI-1 transcripts were more abundant in ob/ob mice (Fig. 6) . In contrast, the USP2-69 mRNA level was decreased by ϳ20% in ob/ob mice, whereas there was no difference in USP2-45 expression. Thus, aberrant expression of USP2-69 was shown in ATMs from obese mice.
Overexpression of USP2-69 causes functional changes in macrophages in vivo
To identify a role of USP2-69 in macrophages in vivo, we generated TG mice overexpressing USP2-69 in macrophages. We introduced a USP2-69 transgene driven by a FIRE promoter, which yields intense expression of genes in macrophages (Fig. 7A and ref. 19 ). Peritoneal 
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See Fig. 5 . GeneSpring GX pathway program using the default setting predicted 3 pathways to be significantly (PϽ0.01 and Ͼ2 microarray candidate genes are included) overrepresented in USP2-KD cell-conditioned adipocytes compared with those in mocktransfected control cells. Official gene symbols are shown. Figure 5 . Effects of USP2-KD cell-derived supernatant on 3T3-L1 adipocytes. 3T3-L1 adipocytes were treated with supernatants from USP2-KD or control cells for 3 or 6 h, and 69 genes whose expression was increased in USP2KD cell-conditioned 3T3-L1 were further analyzed by bioinformatic (A and Table 1 ) and qRT-PCR analyses (B). Table 1 macrophages exhibited a Ͼ100-fold excess of endogenous USP2-69 transcripts in USP2-69 TG mice (Fig. 7B) . Similarly, immune organs such as the spleen and lymph nodes expressed both USP2-69 and a monocyte/macrophage marker CD68 at high levels in TG mice. Furthermore, USP2-69 protein was increased in peritoneal macrophages in USP2-69 TG mice, although the increases in the protein levels were modest (ϳ2-fold; Fig. 7C ).
Next, USP2-69 TG mice and littermates were fed a HFD, starting at 5 wk postpartum. After 14 wk of the HFD, we monitored expression levels of USP2 variants and their potential target genes. As we expected, ATMs from mesenteric adipose tissue of TG mice showed remarkable increases in USP2-69 transcripts, but not n USP2-45 transcripts (Fig. 7D) . The cells also showed a ϳ40% reduction in expression of aP2, PAI-1, and CXCL7 transcripts, whereas expression of HMGA2, PN-1, MMP1, MMP7, CCL2, CCL7, and CCL24 was not modulated (Fig. 7D and unpublished data) . At this time point, the number of macrophages in mesenteric adipose tissue was apparently reduced in TG mice, compared with that in control littermates (Fig. 7E) . These results collectively suggest that USP2-69 modulates the function of macrophages in mesenteric adipose tissue.
Changes in histone modifications at the aP2 locus in USP2-KD cells
We attempted to clarify the molecular events contributing to the expression changes in metabolic disorderassociated molecules in USP2-KD cells. Although USP2-69 can inhibit the nuclear factor-B (NF-B) pathway in the liver (29) ; protein levels of NF-Bp65, phospho-NF-Bp65, or cytoplasmic IB␣, and the binding activity of NF-B were not influenced in USP2-KD HL-60 cells (Supplemental Figs. S3A and S4) . In addition, polyubiquitination of IB␣ was not affected in USP2-KD cells (Supplemental Fig. S3A ).
USP2-45 regulates CCAAT-enhancer-binding protein (C/EBP) ␣, leading to the production of a metabolic enzyme in hepatocytes (15) . However, USP2 deficiency did not modulate cellular content of phospho-C/EBP␣ and total C/EBP␣ or binding activity of total C/EBP (Supplemental Figs. S3B and S4) .
Three mitogen-activated protein kinase (MAPK) family members-namely extracellular signal-regulated kinase (ERK), p38, and c-Jun NH 2 -terminal kinase (JNK)-are known to modulate C/EBP␣ (30) and participate in CCL2 induction (31) . Phosphorylation of the MAPKs and downstream transcription factor, c-Jun, was not affected in USP2-KD cells (Supplemental Fig.  S3C ). Moreover, polyubiquitination and the total amount of MAPK phosphatase (MKP) 1 and 2 were not altered in USP2-KD cells (Supplemental Fig. S3C ). Chemical inhibitors of MAPK kinase (an upstream kinase of ERK), p38, and JNK did not attenuate USP2-KD-elicited aP2 induction (Supplemental Fig. S3C ), although the same doses of inhibitors attenuated phosphorylation of the target kinases (data not shown).
We also found that USP2 deficiency had marginal effects on the peroxisome proliferator-activated receptor (PPAR)-and signal transducer and activator of transcription (STAT)-signaling pathways (Supplemental Figs. S3D, E and S4), all of which can regulate aP2 and chemokine expression (31) (32) (33) . Akt kinase, hypoxia-inducible factor-1 (HIF-1) and forkhead box protein O1 (FOXO1) were also negligibly affected (Supplemental Figs. S3F and S4) . Collectively, these results suggest that the other transcriptional machinery will be involved in the USP2-mediated events.
We next evaluated whether epigenetic regulation contributes to the effects of USP2 deficiency. We assessed the chromatin accessibility of proximal promoter regions using the EpiQ PCR system. Compared with that for control cells, accessibility of the 5= flanking region of aP2 and HMGA2 genes was more than 2-fold increased in USP2-KD cells after PMA application (Fig. 8A) . These increases were inhibited by transfection of USP2-69 but not by the isopeptidase-inactive mutant (Fig. 8B) . Thus, USP2-69 modifies chromatin conformation of the aP2 and HMGA2 genes in an ubiquitinisopeptidase-dependent manner.
We also examined whether USP2 had a global impact on histone acetylation and methylation. As shown in Supplemental Fig. S5A , the total amounts of H4K5ac, H4K8ac, H4K12ac, H4K16ac, H3K4me1, H3K4me2, and H3K4m3 were indistinguishable between USP2-KD cells and control cells. Similarly, ectopic expression of HAtagged USP2-69 had marginal effects on the total amount of the modified histone in HeLa and 293FT cells (Supplemental Fig. S5B and unpublished data) . In agreement, USP2-KD cells and HA-tagged USP2-69-transfected 293FT cells showed negligible changes in the total amounts of histone deacetylases (HDACs), ϩ and CD11b ϩ macrophages were isolated from the epididymal adipose tissue of ob/ob and control lean C57BL/6 ϩ/ϩ mice at 12 wk. USP2 variants, aP2, HMGA2, and PAI-1 mRNA levels were quantified by qRT-PCR. Data are normalized with HPRT-1 mRNA levels and are means Ϯ sd of 3 samples. *P Ͻ 0.05 vs. control C57BL/6 ϩ/ϩ mice.
histone methylases (KMTs) and demethylases (KDMs; Supplemental Fig. S5C ).
To further characterize epigenetic control of the aP2 gene by USP2, we performed ChIP-PCR analysis, targeting histone modifications. With regard to histone H4, USP2 deficiency resulted in increased acetylation of histone H4 (H4K5ac, H4K8ac, and H4K12ac), which indicates transcriptional activation of the aP2 locus (Fig. 8C) . In addition, USP2 KD also increased the level of methylation of histone H3 lysine 4 (H3K4me1, H3K4me2, and H3K4me3) at the locus, whereas USP2 KD did not affect the generepressive marker, histone H3 methylation of lysine 9. Thus, aP2 gene expression is associated with histone modification and chromatin accessibility by USP2.
USP2-69 localizes to the nucleus as well as the cytoplasm
To test how USP2 directly affects the epigenetic machinery in the nucleus, we transfected USP2 expression constructs into HeLa cells to determine the subcellular localization of the USP2 variants. EGFP-tagged USP2-69 and USP2-45 proteins were localized predominantly in the cytoplasmic region (Fig. 9A) . In cells treated with a nuclear export inhibitor, LMB, for 2 h, USP2-69 accumulated as granules in the nucleus. A minor fraction of of type 2 diabetes (1, 3) . Because USP2 exon usage was changed during macrophage-like differentiation of human myeloid cell lines and is thought to participate in regulation of energy metabolism in other cell types (11, 12, 15) , this study focused on the roles of USP2 in the macrophage differentiation process. A previous report demonstrated that USP2-69 and USP2-45 contribute to myogenesis (34) . Thus, we initially assessed whether USP2 variants participate in macrophage-like differentiation. Knockdown of USP2 in myeloid-like cell lines did not cause changes in proliferation, cell cycle progression, or surface expression of macrophage markers on differentiation, indicating that USP2 is not required for PMA-elicited macrophage-like differentiation.
Microarray analysis demonstrated that several genes are negatively controlled by USP2. Furthermore, a substantial fraction of these genes is associated with exacerbation of a metabolic abnormality, e.g., macrophage aP2 contributes to the pathogenesis of type 2 diabetes and atherosclerosis (25) , whereas CCL2 is required for infiltration of macrophages into visceral fat as well as atherosclerotic plaques (2, 3) . PAI-1 and PN-1 are directly involved in the development of obesity, diabetic renal fibrosis, and cardiovascular disease (35) (36) (37) . MMP1 and MMP7 were postulated to promote development of atherosclerotic plaques and adipocyte differentiation (38 -41) . Hence, USP2 in ATMs seems to be a novel factor conferring the effects of metabolic defects.
USP2 KD in myeloid cells resulted in depletion of both USP2 variants. By selective rescue, we were able to investigate the particular roles of each variant. Notably, overexpression of USP2-69 prevented production of metabolic disorder-associated molecules such as aP2, PAI-1, PN-1, and MMPs, whereas overexpression of USP2-45 exaggerated induction of these molecules. It has been reported that USP2-45, but not USP2-69, up-regulates 11␤-hydroxysteroid dehydrogenase 1 in hepatocytes, therefore promoting glyconeogenesis (15) . Based on this observation, the authors proposed that USP2-45 aggravates type 2 diabetes, which is consistent with our findings. Taken together, these results show that USP2-69 and USP2-45 most likely have distinct, perhaps opposing, roles in metabolic deterioration, similar to their roles in myotube formation and carcinogenesis (8, 34, 42) .
In our study, the conditioning of 3T3-L1 cells using supernatants from USP2-KD cells led to expression of a set of molecules, in which inflammatory and adipogenic molecules were overrepresented. Of these, IL-6 can confer insulin resistance to 3T3-L1 cells through induction of suppressor of cytokine signaling 3 (SOCS3; refs. 43, 44) . Thus, the IL-6-SOCS3 axis may contribute to the insulin hyposensitivity of adipocytes. SAA3, another molecule induced by the conditioning, enables monocytes to infiltrate adipose tissues (45) , whereas early growth response protein 2 (EGR2) is known to be an adipogenic factor (46) . Therefore, USP2 deficiency in macrophages may lead to adipogenesis and adipose tissue inflammation, both of which are fundamental prediabetic events.
In this study, USP2-69 TG mice displayed repression of aP2, PAI-1, and CXCL7 expression in ATMs of mesenteric adipose tissue, indicating that the regulatory roles of USP2-69 are relevant in vivo. However, gene expression changes in ATMs of the TG mice were quite modest. Of 10 putative USP2 target genes defined by the cultured cell study, only 3 were significantly modulated. USP2-69 was increased by more than several hundred-fold at the transcript level but only by ϳ2-fold at the protein level in macrophages of the TG mice. Post-transcriptional and/or post-translational controls may prevent excessive production of USP2 protein in these cells. The limited production of USP2-69 protein may explain the modest phenotypic changes seen in USP2-69 TG mice. Further studies using TG mice and USP2 conditional knockout mice may clarify how much of an effect macrophages have on metabolic defects in vivo.
USP2-69 TG mice showed a slight decrease in the number of macrophages infiltrating into the mesenteric adipose tissue. In our preliminary study, there were few annexin V ϩ and 7-aminoactinomycin D Ϫ apoptotic cells among the F4/80 ϩ and CD11 ϩ macrophages in the adipose tissues and peritoneal cavity of TG mice. Therefore, apoptosis is less likely to be responsible for the decrease in macrophages in these tissues. A more likely explanation for the decrease in macrophage numbers is reduced expression of chemokines such as CXCL7 in mesenteric adipose tissue. This chemokine is proteolytically cleaved into a strong chemoattractant for neutrophils (47) . Because neutrophils are proposed to be important initiators of adipose tissue inflammation (48), a decrease in CXCL7 production by macrophages of USP2-69 TG mice may attenuate the infiltration of neutrophils into adipose tissue, ultimately leading to repression of adipose tissue inflammation.
Our current study using the isopeptidase-deficient USP2-69 mutant demonstrated that the isopeptidase region in USP2-69 is responsible for suppression of the metabolic disorder-associated genes we have examined. Clearly, USP2-45 cannot compensate, even though this variant shares the same isopeptidase region in its C-terminal tail. Structural differences at the N terminus between the variants are known to have a strong effect on enzymatic activity as well as on cellular localization (49, 50) . In accordance with this, USP2-69 preferentially localized in the nucleus in HL-60 cells, unlike USP2-45. These observations suggest that both isopeptidase activity and nuclear translocation of USP2-69 are required for modulating these molecules.
Previous articles have documented the fact that USP2 regulates several signaling pathways including the NF-B and C/EBP␣ pathways (15, 29) . However, these pathways are not likely to regulate the USP2-KD-elicited events because neither their phosphorylation nor activity of the signaling molecules was affected in macrophages. Notably, our study suggests that USP2 defi-ciency promotes chromatin accessibility at the aP2 locus through histone modification. These data propose the novel concept that USP2 may be associated with epigenetic modifiers that repress the expression of molecules associated with chronic inflammation. Because USP2-69 temporally localizes in nuclear granular structures, it seems to modulate the epigenetic machinery in the nucleus. Nuclear molecules mediating the USP2-elicited epigenetic control should be clarified in further studies.
In summary, USP2-69 in macrophages suppresses metabolic disorder-associated molecules in a relatively selective manner. Because macrophages in visceral adipose tissues function as key accelerators of metabolic syndrome, USP2 has the potential to be an effective therapeutic target.
